Program:
Almost all modern drug discovery efforts, whether based on screening, structure-based design or other approaches, depend on the selection of biomolecular targets. The development of breakthrough drugs is even more dependent on finding novel targets. Receptors, enzymes, genes and other biomolecules, both from humans and from infectious organisms, can be appropriate targets once unique functionality has been recognized. A number of strategies for identifying such targets, including genome-based approaches, will be explored.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02164
USA
tel: 617-630-1300
fax: 617-630-1325
Deadline for Abstracts: 8/95
Email for Requests and Registration: chi@healthtech.com